How big is the sophocarpidine cas519028 market?

Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.

Market Analysis and Insights: Global Sophocarpidine (CAS：519-02-8) Market

Due to the COVID-19 pandemic, the global Sophocarpidine (CAS：519-02-8) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, High Purity accounting for % of the Sophocarpidine (CAS：519-02-8) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.

China Sophocarpidine (CAS：519-02-8) market size is valued at US$ million in 2021, while the US and Europe Sophocarpidine (CAS：519-02-8) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Sophocarpidine (CAS：519-02-8) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Sophocarpidine (CAS：519-02-8) include Fujie Pharmaceutical, QHL Pharma, Select Botanical, Indena, TIANSHAN Pharmaceuticals, Selco Wirkstoffe Vertriebs GmbH, Jiangsu Tiansheng Pharmaceutical, Tiansheng Pharmaceutical and Hubei Zhongliao Chemical Co., LTD. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Sophocarpidine (CAS：519-02-8) Scope and Segment

Sophocarpidine (CAS：519-02-8) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Sophocarpidine (CAS：519-02-8) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

High Purity

Low Purity

Segment by Application

Pharmaceuticals

Pesticides

Others

BY COMPANY

Fujie Pharmaceutical

QHL Pharma

Select Botanical

Indena

TIANSHAN Pharmaceuticals

Selco Wirkstoffe Vertriebs GmbH

Jiangsu Tiansheng Pharmaceutical

Tiansheng Pharmaceutical

Hubei Zhongliao Chemical Co., LTD

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

TIANSHAN Pharmaceuticals

Selco Wirkstoffe Vertriebs GmbH

Jiangsu Tiansheng Pharmaceutical

Tiansheng Pharmaceutical

Hubei Zhongliao Chemical Co., LTD

1 Study Coverage

1.1 Sophocarpidine (CAS：519-02-8) Product Introduction

1.2 Market by Type

1.2.1 Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 High Purity

1.2.3 Low Purity

1.3 Market by Application

1.3.1 Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Pharmaceuticals

1.3.3 Pesticides

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Sophocarpidine (CAS：519-02-8) Sales Estimates and Forecasts 2017-2028

2.2 Global Sophocarpidine (CAS：519-02-8) Revenue Estimates and Forecasts 2017-2028

2.3 Global Sophocarpidine (CAS：519-02-8) Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Sophocarpidine (CAS：519-02-8) Sales by Region

2.4.1 Global Sophocarpidine (CAS：519-02-8) Sales by Region (2017-2022)

2.4.2 Global Sales Sophocarpidine (CAS：519-02-8) by Region (2023-2028)

2.5 Global Sophocarpidine (CAS：519-02-8) Revenue by Region

2.5.1 Global Sophocarpidine (CAS：519-02-8) Revenue by Region (2017-2022)

2.5.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Sophocarpidine (CAS：519-02-8) Sales by Manufacturers

3.1.1 Global Top Sophocarpidine (CAS：519-02-8) Manufacturers by Sales (2017-2022)

3.1.2 Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sophocarpidine (CAS：519-02-8) in 2021

3.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Manufacturers

3.2.1 Global Sophocarpidine (CAS：519-02-8) Revenue by Manufacturers (2017-2022)

3.2.2 Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Sophocarpidine (CAS：519-02-8) Revenue in 2021

3.3 Global Sophocarpidine (CAS：519-02-8) Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Sophocarpidine (CAS：519-02-8) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Sophocarpidine (CAS：519-02-8) Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Sophocarpidine (CAS：519-02-8) Sales by Type

4.1.1 Global Sophocarpidine (CAS：519-02-8) Historical Sales by Type (2017-2022)

4.1.2 Global Sophocarpidine (CAS：519-02-8) Forecasted Sales by Type (2023-2028)

4.1.3 Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2017-2028)

4.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Type

4.2.1 Global Sophocarpidine (CAS：519-02-8) Historical Revenue by Type (2017-2022)

4.2.2 Global Sophocarpidine (CAS：519-02-8) Forecasted Revenue by Type (2023-2028)

4.2.3 Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2017-2028)

4.3 Global Sophocarpidine (CAS：519-02-8) Price by Type

4.3.1 Global Sophocarpidine (CAS：519-02-8) Price by Type (2017-2022)

4.3.2 Global Sophocarpidine (CAS：519-02-8) Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Sophocarpidine (CAS：519-02-8) Sales by Application

5.1.1 Global Sophocarpidine (CAS：519-02-8) Historical Sales by Application (2017-2022)

5.1.2 Global Sophocarpidine (CAS：519-02-8) Forecasted Sales by Application (2023-2028)

5.1.3 Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2017-2028)

5.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Application

5.2.1 Global Sophocarpidine (CAS：519-02-8) Historical Revenue by Application (2017-2022)

5.2.2 Global Sophocarpidine (CAS：519-02-8) Forecasted Revenue by Application (2023-2028)

5.2.3 Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2017-2028)

5.3 Global Sophocarpidine (CAS：519-02-8) Price by Application

5.3.1 Global Sophocarpidine (CAS：519-02-8) Price by Application (2017-2022)

5.3.2 Global Sophocarpidine (CAS：519-02-8) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Sophocarpidine (CAS：519-02-8) Market Size by Type

6.1.1 North America Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2028)

6.1.2 North America Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2028)

6.2 North America Sophocarpidine (CAS：519-02-8) Market Size by Application

6.2.1 North America Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2028)

6.2.2 North America Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2028)

6.3 North America Sophocarpidine (CAS：519-02-8) Market Size by Country

6.3.1 North America Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2028)

6.3.2 North America Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Sophocarpidine (CAS：519-02-8) Market Size by Type

7.1.1 Europe Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2028)

7.1.2 Europe Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2028)

7.2 Europe Sophocarpidine (CAS：519-02-8) Market Size by Application

7.2.1 Europe Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2028)

7.2.2 Europe Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2028)

7.3 Europe Sophocarpidine (CAS：519-02-8) Market Size by Country

7.3.1 Europe Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2028)

7.3.2 Europe Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Sophocarpidine (CAS：519-02-8) Market Size by Type

8.1.1 Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2028)

8.1.2 Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2028)

8.2 Asia Pacific Sophocarpidine (CAS：519-02-8) Market Size by Application

8.2.1 Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2028)

8.2.2 Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2028)

8.3 Asia Pacific Sophocarpidine (CAS：519-02-8) Market Size by Region

8.3.1 Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Region (2017-2028)

8.3.2 Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Sophocarpidine (CAS：519-02-8) Market Size by Type

9.1.1 Latin America Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2028)

9.1.2 Latin America Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2028)

9.2 Latin America Sophocarpidine (CAS：519-02-8) Market Size by Application

9.2.1 Latin America Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2028)

9.2.2 Latin America Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2028)

9.3 Latin America Sophocarpidine (CAS：519-02-8) Market Size by Country

9.3.1 Latin America Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2028)

9.3.2 Latin America Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Size by Type

10.1.1 Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2028)

10.1.2 Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2028)

10.2 Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Size by Application

10.2.1 Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2028)

10.2.2 Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2028)

10.3 Middle East and Africa Sophocarpidine (CAS：519-02-8) Market Size by Country

10.3.1 Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2028)

10.3.2 Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Fujie Pharmaceutical

11.1.1 Fujie Pharmaceutical Corporation Information

11.1.2 Fujie Pharmaceutical Overview

11.1.3 Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Fujie Pharmaceutical Recent Developments

11.2 QHL Pharma

11.2.1 QHL Pharma Corporation Information

11.2.2 QHL Pharma Overview

11.2.3 QHL Pharma Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 QHL Pharma Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 QHL Pharma Recent Developments

11.3 Select Botanical

11.3.1 Select Botanical Corporation Information

11.3.2 Select Botanical Overview

11.3.3 Select Botanical Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Select Botanical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Select Botanical Recent Developments

11.4 Indena

11.4.1 Indena Corporation Information

11.4.2 Indena Overview

11.4.3 Indena Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Indena Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Indena Recent Developments

11.5 TIANSHAN Pharmaceuticals

11.5.1 TIANSHAN Pharmaceuticals Corporation Information

11.5.2 TIANSHAN Pharmaceuticals Overview

11.5.3 TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 TIANSHAN Pharmaceuticals Recent Developments

11.6 Selco Wirkstoffe Vertriebs GmbH

11.6.1 Selco Wirkstoffe Vertriebs GmbH Corporation Information

11.6.2 Selco Wirkstoffe Vertriebs GmbH Overview

11.6.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Selco Wirkstoffe Vertriebs GmbH Recent Developments

11.7 Jiangsu Tiansheng Pharmaceutical

11.7.1 Jiangsu Tiansheng Pharmaceutical Corporation Information

11.7.2 Jiangsu Tiansheng Pharmaceutical Overview

11.7.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Jiangsu Tiansheng Pharmaceutical Recent Developments

11.8 Tiansheng Pharmaceutical

11.8.1 Tiansheng Pharmaceutical Corporation Information

11.8.2 Tiansheng Pharmaceutical Overview

11.8.3 Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Tiansheng Pharmaceutical Recent Developments

11.9 Hubei Zhongliao Chemical Co., LTD

11.9.1 Hubei Zhongliao Chemical Co., LTD Corporation Information

11.9.2 Hubei Zhongliao Chemical Co., LTD Overview

11.9.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Hubei Zhongliao Chemical Co., LTD Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Sophocarpidine (CAS：519-02-8) Industry Chain Analysis

12.2 Sophocarpidine (CAS：519-02-8) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Sophocarpidine (CAS：519-02-8) Production Mode & Process

12.4 Sophocarpidine (CAS：519-02-8) Sales and Marketing

12.4.1 Sophocarpidine (CAS：519-02-8) Sales Channels

12.4.2 Sophocarpidine (CAS：519-02-8) Distributors

12.5 Sophocarpidine (CAS：519-02-8) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Sophocarpidine (CAS：519-02-8) Industry Trends

13.2 Sophocarpidine (CAS：519-02-8) Market Drivers

13.3 Sophocarpidine (CAS：519-02-8) Market Challenges

13.4 Sophocarpidine (CAS：519-02-8) Market Restraints

14 Key Findings in The Global Sophocarpidine (CAS：519-02-8) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

TIANSHAN Pharmaceuticals

Selco Wirkstoffe Vertriebs GmbH

Jiangsu Tiansheng Pharmaceutical

Tiansheng Pharmaceutical

Hubei Zhongliao Chemical Co., LTD

List of Tables

Table 1. Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of High Purity

Table 3. Major Manufacturers of Low Purity

Table 4. Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Sophocarpidine (CAS：519-02-8) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Sophocarpidine (CAS：519-02-8) Sales by Region (2017-2022) & (K MT)

Table 7. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Region (2017-2022)

Table 8. Global Sophocarpidine (CAS：519-02-8) Sales by Region (2023-2028) & (K MT)

Table 9. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Region (2023-2028)

Table 10. Global Sophocarpidine (CAS：519-02-8) Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Region (2017-2022)

Table 12. Global Sophocarpidine (CAS：519-02-8) Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Region (2023-2028)

Table 14. Global Sophocarpidine (CAS：519-02-8) Sales by Manufacturers (2017-2022) & (K MT)

Table 15. Global Sophocarpidine (CAS：519-02-8) Sales Share by Manufacturers (2017-2022)

Table 16. Global Sophocarpidine (CAS：519-02-8) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Sophocarpidine (CAS：519-02-8) Revenue Share by Manufacturers (2017-2022)

Table 18. Sophocarpidine (CAS：519-02-8) Price by Manufacturers (2017-2022) &(USD/MT)

Table 19. Global Sophocarpidine (CAS：519-02-8) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Sophocarpidine (CAS：519-02-8) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sophocarpidine (CAS：519-02-8) as of 2021)

Table 21. Sophocarpidine (CAS：519-02-8) Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Sophocarpidine (CAS：519-02-8) Product Offered

Table 23. Date of Manufacturers Enter into Sophocarpidine (CAS：519-02-8) Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2022) & (K MT)

Table 26. Global Sophocarpidine (CAS：519-02-8) Sales by Type (2023-2028) & (K MT)

Table 27. Global Sophocarpidine (CAS：519-02-8) Sales Share by Type (2017-2022)

Table 28. Global Sophocarpidine (CAS：519-02-8) Sales Share by Type (2023-2028)

Table 29. Global Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Sophocarpidine (CAS：519-02-8) Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Sophocarpidine (CAS：519-02-8) Revenue Share by Type (2017-2022)

Table 32. Global Sophocarpidine (CAS：519-02-8) Revenue Share by Type (2023-2028)

Table 33. Sophocarpidine (CAS：519-02-8) Price by Type (2017-2022) & (USD/MT)

Table 34. Global Sophocarpidine (CAS：519-02-8) Price Forecast by Type (2023-2028) & (USD/MT)

Table 35. Global Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2022) & (K MT)

Table 36. Global Sophocarpidine (CAS：519-02-8) Sales by Application (2023-2028) & (K MT)

Table 37. Global Sophocarpidine (CAS：519-02-8) Sales Share by Application (2017-2022)

Table 38. Global Sophocarpidine (CAS：519-02-8) Sales Share by Application (2023-2028)

Table 39. Global Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Sophocarpidine (CAS：519-02-8) Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Sophocarpidine (CAS：519-02-8) Revenue Share by Application (2017-2022)

Table 42. Global Sophocarpidine (CAS：519-02-8) Revenue Share by Application (2023-2028)

Table 43. Sophocarpidine (CAS：519-02-8) Price by Application (2017-2022) & (USD/MT)

Table 44. Global Sophocarpidine (CAS：519-02-8) Price Forecast by Application (2023-2028) & (USD/MT)

Table 45. North America Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2022) & (K MT)

Table 46. North America Sophocarpidine (CAS：519-02-8) Sales by Type (2023-2028) & (K MT)

Table 47. North America Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Sophocarpidine (CAS：519-02-8) Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2022) & (K MT)

Table 50. North America Sophocarpidine (CAS：519-02-8) Sales by Application (2023-2028) & (K MT)

Table 51. North America Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Sophocarpidine (CAS：519-02-8) Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2022) & (K MT)

Table 54. North America Sophocarpidine (CAS：519-02-8) Sales by Country (2023-2028) & (K MT)

Table 55. North America Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Sophocarpidine (CAS：519-02-8) Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2022) & (K MT)

Table 58. Europe Sophocarpidine (CAS：519-02-8) Sales by Type (2023-2028) & (K MT)

Table 59. Europe Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Sophocarpidine (CAS：519-02-8) Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2022) & (K MT)

Table 62. Europe Sophocarpidine (CAS：519-02-8) Sales by Application (2023-2028) & (K MT)

Table 63. Europe Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Sophocarpidine (CAS：519-02-8) Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2022) & (K MT)

Table 66. Europe Sophocarpidine (CAS：519-02-8) Sales by Country (2023-2028) & (K MT)

Table 67. Europe Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Sophocarpidine (CAS：519-02-8) Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2022) & (K MT)

Table 70. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Type (2023-2028) & (K MT)

Table 71. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2022) & (K MT)

Table 74. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Application (2023-2028) & (K MT)

Table 75. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Region (2017-2022) & (K MT)

Table 78. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales by Region (2023-2028) & (K MT)

Table 79. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2022) & (K MT)

Table 82. Latin America Sophocarpidine (CAS：519-02-8) Sales by Type (2023-2028) & (K MT)

Table 83. Latin America Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Sophocarpidine (CAS：519-02-8) Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2022) & (K MT)

Table 86. Latin America Sophocarpidine (CAS：519-02-8) Sales by Application (2023-2028) & (K MT)

Table 87. Latin America Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Sophocarpidine (CAS：519-02-8) Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2022) & (K MT)

Table 90. Latin America Sophocarpidine (CAS：519-02-8) Sales by Country (2023-2028) & (K MT)

Table 91. Latin America Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Sophocarpidine (CAS：519-02-8) Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Type (2017-2022) & (K MT)

Table 94. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Type (2023-2028) & (K MT)

Table 95. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Application (2017-2022) & (K MT)

Table 98. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Application (2023-2028) & (K MT)

Table 99. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Country (2017-2022) & (K MT)

Table 102. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales by Country (2023-2028) & (K MT)

Table 103. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue by Country (2023-2028) & (US$ Million)

Table 105. Fujie Pharmaceutical Corporation Information

Table 106. Fujie Pharmaceutical Description and Major Businesses

Table 107. Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 108. Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Fujie Pharmaceutical Recent Developments

Table 110. QHL Pharma Corporation Information

Table 111. QHL Pharma Description and Major Businesses

Table 112. QHL Pharma Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 113. QHL Pharma Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. QHL Pharma Recent Developments

Table 115. Select Botanical Corporation Information

Table 116. Select Botanical Description and Major Businesses

Table 117. Select Botanical Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 118. Select Botanical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Select Botanical Recent Developments

Table 120. Indena Corporation Information

Table 121. Indena Description and Major Businesses

Table 122. Indena Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 123. Indena Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Indena Recent Developments

Table 125. TIANSHAN Pharmaceuticals Corporation Information

Table 126. TIANSHAN Pharmaceuticals Description and Major Businesses

Table 127. TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 128. TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. TIANSHAN Pharmaceuticals Recent Developments

Table 130. Selco Wirkstoffe Vertriebs GmbH Corporation Information

Table 131. Selco Wirkstoffe Vertriebs GmbH Description and Major Businesses

Table 132. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 133. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Selco Wirkstoffe Vertriebs GmbH Recent Developments

Table 135. Jiangsu Tiansheng Pharmaceutical Corporation Information

Table 136. Jiangsu Tiansheng Pharmaceutical Description and Major Businesses

Table 137. Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 138. Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Jiangsu Tiansheng Pharmaceutical Recent Developments

Table 140. Tiansheng Pharmaceutical Corporation Information

Table 141. Tiansheng Pharmaceutical Description and Major Businesses

Table 142. Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 143. Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Tiansheng Pharmaceutical Recent Developments

Table 145. Hubei Zhongliao Chemical Co., LTD Corporation Information

Table 146. Hubei Zhongliao Chemical Co., LTD Description and Major Businesses

Table 147. Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 148. Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Hubei Zhongliao Chemical Co., LTD Recent Developments

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Sophocarpidine (CAS：519-02-8) Distributors List

Table 153. Sophocarpidine (CAS：519-02-8) Customers List

Table 154. Sophocarpidine (CAS：519-02-8) Market Trends

Table 155. Sophocarpidine (CAS：519-02-8) Market Drivers

Table 156. Sophocarpidine (CAS：519-02-8) Market Challenges

Table 157. Sophocarpidine (CAS：519-02-8) Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Sophocarpidine (CAS：519-02-8) Product Picture

Figure 3. Global Sophocarpidine (CAS：519-02-8) Market Share by Type in 2021 & 2028

Figure 3. High Purity Product Picture

Figure 4. Low Purity Product Picture

Figure 5. Global Sophocarpidine (CAS：519-02-8) Market Share by Application in 2021 & 2028

Figure 6. Pharmaceuticals

Figure 7. Pesticides

Figure 8. Others

Figure 9. Sophocarpidine (CAS：519-02-8) Report Years Considered

Figure 10. Global Sophocarpidine (CAS：519-02-8) Sales 2017-2028 (K MT)

Figure 11. Global Sophocarpidine (CAS：519-02-8) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Sophocarpidine (CAS：519-02-8) Revenue 2017-2028 (US$ Million)

Figure 13. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 14. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Region (2017-2022)

Figure 15. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Region (2023-2028)

Figure 16. North America Sophocarpidine (CAS：519-02-8) Sales YoY (2017-2028) & (K MT)

Figure 17. North America Sophocarpidine (CAS：519-02-8) Revenue YoY (2017-2028) & (US$ Million)

Figure 18. Europe Sophocarpidine (CAS：519-02-8) Sales YoY (2017-2028) & (K MT)

Figure 19. Europe Sophocarpidine (CAS：519-02-8) Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Asia-Pacific Sophocarpidine (CAS：519-02-8) Sales YoY (2017-2028) & (K MT)

Figure 21. Asia-Pacific Sophocarpidine (CAS：519-02-8) Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Latin America Sophocarpidine (CAS：519-02-8) Sales YoY (2017-2028) & (K MT)

Figure 23. Latin America Sophocarpidine (CAS：519-02-8) Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Middle East & Africa Sophocarpidine (CAS：519-02-8) Sales YoY (2017-2028) & (K MT)

Figure 25. Middle East & Africa Sophocarpidine (CAS：519-02-8) Revenue YoY (2017-2028) & (US$ Million)

Figure 26. The Sophocarpidine (CAS：519-02-8) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 27. The Top 5 and 10 Largest Manufacturers of Sophocarpidine (CAS：519-02-8) in the World: Market Share by Sophocarpidine (CAS：519-02-8) Revenue in 2021

Figure 28. Global Sophocarpidine (CAS：519-02-8) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 29. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2017-2028)

Figure 30. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2017-2028)

Figure 31. Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2017-2028)

Figure 32. Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2017-2028)

Figure 33. North America Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2017-2028)

Figure 34. North America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2017-2028)

Figure 35. North America Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2017-2028)

Figure 36. North America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2017-2028)

Figure 37. North America Sophocarpidine (CAS：519-02-8) Sales Share by Country (2017-2028)

Figure 38. North America Sophocarpidine (CAS：519-02-8) Revenue Share by Country (2017-2028)

Figure 39. U.S. Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 40. Canada Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 41. Europe Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2017-2028)

Figure 42. Europe Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2017-2028)

Figure 43. Europe Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2017-2028)

Figure 44. Europe Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2017-2028)

Figure 45. Europe Sophocarpidine (CAS：519-02-8) Sales Share by Country (2017-2028)

Figure 46. Europe Sophocarpidine (CAS：519-02-8) Revenue Share by Country (2017-2028)

Figure 47. Germany Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 48. France Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 49. U.K. Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 50. Italy Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 51. Russia Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 52. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2017-2028)

Figure 53. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2017-2028)

Figure 54. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2017-2028)

Figure 55. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2017-2028)

Figure 56. Asia Pacific Sophocarpidine (CAS：519-02-8) Sales Share by Region (2017-2028)

Figure 57. Asia Pacific Sophocarpidine (CAS：519-02-8) Revenue Share by Region (2017-2028)

Figure 58. China Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 59. Japan Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 60. South Korea Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 61. India Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 62. Australia Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 63. China Taiwan Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 64. Indonesia Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 65. Thailand Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 66. Malaysia Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 67. Latin America Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2017-2028)

Figure 68. Latin America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2017-2028)

Figure 69. Latin America Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2017-2028)

Figure 70. Latin America Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2017-2028)

Figure 71. Latin America Sophocarpidine (CAS：519-02-8) Sales Share by Country (2017-2028)

Figure 72. Latin America Sophocarpidine (CAS：519-02-8) Revenue Share by Country (2017-2028)

Figure 73. Mexico Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 74. Brazil Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 75. Argentina Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 76. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Sophocarpidine (CAS：519-02-8) Sales Share by Country (2017-2028)

Figure 81. Middle East and Africa Sophocarpidine (CAS：519-02-8) Revenue Share by Country (2017-2028)

Figure 82. Turkey Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 83. Saudi Arabia Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 84. UAE Sophocarpidine (CAS：519-02-8) Revenue (2017-2028) & (US$ Million)

Figure 85. Sophocarpidine (CAS：519-02-8) Value Chain

Figure 86. Sophocarpidine (CAS：519-02-8) Production Process

Figure 87. Channels of Distribution

Figure 88. Distributors Profiles

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sophocarpidine (CAS：519-02-8) Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-25Q9530

Global Sophocarpidine (CAS：519-02-8) Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions